VSL#3 is a company within the Health & Wellness category. VSL#3 is a high-potency probiotic medical food intended for the dietary management of Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC), and Pouchitis. It consists of a proprietary blend of eight strains of live lactic acid bacteria and bifidobacteria, delivering one of the highest colony-forming unit (CFU) counts available in the market.
VSL#3 is rated Contender on the Optimly Brand Authority Index, a measure of how well AI models can accurately describe the brand. The exact score is locked for unclaimed profiles.
AI narrative accuracy for VSL#3 is Moderate. Significant factual deltas detected.
AI models classify VSL#3 as a Challenger. AI names competitors first.
VSL#3 appeared in 5 of 6 sampled buyer-intent queries (83%). While VSL#3 dominates queries for 'medical probiotic,' it loses share in queries regarding the 'De Simone formulation' or 'original VSL#3 formula' to competitors.
AI models generally represent VSL#3 as a top-tier medical probiotic for GI health. However, they frequently struggle to distinguish the complex legal and scientific history regarding its formulation change, often attributing historical clinical study results to the current product incorrectly. Key gap: The distinction between the current VSL#3 formulation and the 'original' De Simone formulation (now sold as Visbiome) is often blurred or incorrectly synthesized, leading to outdated claims about clinical trials performed on the old formula.
Of 5 key facts verified about VSL#3, 4 are well-documented (likely accurate across AI models), 1 have limited sourcing, and 0 are retrieval-dependent and may be inaccurate without live search.
Claims regarding 'clinical equivalence' between the current product and the pre-2016 version are often the most inaccurate or contested in AI summaries.
Buyers turn to VSL#3 for Standard Probiotic Foods: Using generic, low-concentration yogurt or kefir to introduce probiotics to the diet., Dietary Management/Elimination: Managing symptoms through restrictive diets like Low-FODMAP without active microbial intervention., among 2 documented problem areas.
Buyers evaluating VSL#3 typically ask AI models about "best probiotic for ulcerative colitis", "high potency probiotic medical food", "original de simone formulation probiotic", and 3 similar queries.
VSL#3's main competitors are Align, Culturelle, Visbiome. According to AI models, these are the brands most frequently named alongside VSL#3 in buyer-intent queries.
VSL#3's core products are VSL#3 Sachets (450 billion CFU), VSL#3 Capsules (112.5 billion CFU), VSL#3 Junior..
VSL#3 uses One-time purchase / Subscription available via retailers.
VSL#3 serves Patients with Ulcerative Colitis, IBS, or Pouchitis under medical supervision..
VSL#3 One of the highest-potency probiotic medical foods on the market, backed by two decades of use in clinical GI settings.
Brand Authority Index (BAI) tier: Contender (exact score locked for unclaimed brands)
Archetype: Challenger
https://optimly.ai/brand/vsl-3
Last analyzed: April 10, 2026
Founded: 2002
Headquarters: Rome, Italy (Actial Farmaceutica) / USA (Alfasigma USA)